Publications
- Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution2020 | First Faculty of Medicine
- Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients)2018 | First Faculty of Medicine
- Komentář ke studii (Léčba esenciální trombocytemie v Evropě - studie EXELS s anagrelidem)2018 | First Faculty of Medicine
- Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes2016 | First Faculty of Medicine
- Molecular cytogenetic analysis of dicentric chromosomes in acute myeloid leukemia2016 | First Faculty of Medicine
- Lenalidomide treatment in myelodysplastic syndrome with 5q deletion - Czech MDS group experience2015 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide2015 | Faculty of Science
- Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis2014 | First Faculty of Medicine
- Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q-syndrome and in Diamond-Blackfan anemia2013 | First Faculty of Medicine
- Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites2012 | First Faculty of Medicine
Loading network view...